Details
Stereochemistry | ACHIRAL |
Molecular Formula | C17H16FN3 |
Molecular Weight | 281.3274 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)C1=NC(N)=NC(=C1)C2=CC=C(F)C3=CC=CC=C23
InChI
InChIKey=ZZZQXCUPAJFVBN-UHFFFAOYSA-N
InChI=1S/C17H16FN3/c1-10(2)15-9-16(21-17(19)20-15)13-7-8-14(18)12-6-4-3-5-11(12)13/h3-10H,1-2H3,(H2,19,20,21)
Molecular Formula | C17H16FN3 |
Molecular Weight | 281.3274 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/10455251 | https://www.ncbi.nlm.nih.gov/pubmed/16517693Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/11575715
Sources: https://www.ncbi.nlm.nih.gov/pubmed/10455251 | https://www.ncbi.nlm.nih.gov/pubmed/16517693
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/11575715
RS-127445 is a selective; high affinity; orally bioavailable serotonin 5-HT2B receptor antagonist. RS-127445 was found to have a nanomolar affinity for the 5-HT2B receptor (pKi = 9.5 /-0.1) and 1,000 fold selectivity for this receptor as compared to numerous other receptors and ion channel binding sites. RS-127445 potently antagonized 5-HT-evoked formation of inositol phosphates (pK(B) = 9.5 /-0.1) and 5-HT-evoked increases in intracellular calcium (pIC50 = 10.4 /-0.1). RS-127445 also blocked 5-HT-evoked contraction of rat isolated stomach fundus (pA2 = 9.5 /-1.1) and ( /-)alpha-methyl-5-HT-mediated relaxation of the rat jugular vein (pA2 = 9.9 /-0.3). RS-127445 (MT-500) was being developed for the prophylactic treatment of migraine. POZEN acquired MT-500 from Roche in November 1999 and assumed full responsibility for its development for migraine prophylaxis.
CNS Activity
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/ 19740115
Curator's Comment: Can aslo be used i.p. https://www.ncbi.nlm.nih.gov/pubmed/20003079
Rats: oral administration of a selective, high affinity 5-HT(2B)receptor antagonist, RS-127445, significantly inhibited visceral hypersensitivity provoked by restraint stress (35 to 74% inhibition at 1 to 10 mg kg(-1)).
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/10455251
RS-127445 (0.3-3nM) potently inhibited the 5-HT evoked increase in the formation of inositol phosphates in HEK-293 cells expressing the human 5-HT2B receptors, producing parallel rightward shifts in the concentration response curves of 5-HT.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:41:33 GMT 2023
by
admin
on
Fri Dec 15 15:41:33 GMT 2023
|
Record UNII |
0JAU3P8OBM
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
RS-127445
Created by
admin on Fri Dec 15 15:41:33 GMT 2023 , Edited by admin on Fri Dec 15 15:41:33 GMT 2023
|
PRIMARY | |||
|
199864-87-4
Created by
admin on Fri Dec 15 15:41:33 GMT 2023 , Edited by admin on Fri Dec 15 15:41:33 GMT 2023
|
PRIMARY | |||
|
196968
Created by
admin on Fri Dec 15 15:41:33 GMT 2023 , Edited by admin on Fri Dec 15 15:41:33 GMT 2023
|
PRIMARY | |||
|
DTXSID60941960
Created by
admin on Fri Dec 15 15:41:33 GMT 2023 , Edited by admin on Fri Dec 15 15:41:33 GMT 2023
|
PRIMARY | |||
|
0JAU3P8OBM
Created by
admin on Fri Dec 15 15:41:33 GMT 2023 , Edited by admin on Fri Dec 15 15:41:33 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
ANTAGONIST
Ki
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|